I-Retaglutide yinto entsha ye-dipeptidyl peptidase-4 (DPP-4) inhibitor yeklasi ye-hypoglycemic drug enokuthintela ukuthotywa kwe-glucagon-like peptide-1 (GLP-1) kunye ne-glucose-exhomekeke kwi-insulin-ekhulula i-polypeptide (GIP) nge-DPP-4 i-enzyme emathunjini kunye negazi, apho ichaphazela i-insulin eyimfihlo ngokwandisa umsebenzi wabo we-pancreatic, ukwandisa umsebenzi wabo we-insulin. inqanaba lesiseko le-insulin yokuzila, ngelixa linciphisa ukukhuselwa kweglucagon ngamaseli e-pancreatic α, ngaloo ndlela ilawula ngokufanelekileyo iswekile yegazi emva kokutya. Isebenza kakuhle ngokubhekiselele kwimpembelelo ye-hypoglycemic, ukunyamezela, kunye nokuthotyelwa.